Government: Page 46


  • A building with logo of drugmaker Eli Lilly.
    Image attribution tooltip
    Courtesy of Eli Lilly
    Image attribution tooltip

    Lilly to lower insulin prices by 70%

    The pharma company has long been under pressure over the high cost of insulin — scrutiny that has recently ramped up in the U.S.

    By Jonathan Gardner • March 1, 2023
  • Amazon's logo on a smartphone.
    Image attribution tooltip
    Edward Smith via Getty Images
    Image attribution tooltip
    Deep Dive

    Why regulators didn’t challenge Amazon-One Medical deal, despite data concerns

    The ecommerce giant's $3.9 billion buy of primary care company One Medical closed without a challenge from the FTC, even as consumer protection groups and regulators aired worries about the tie-up.

    By March 1, 2023
  • UPMC, top surgeon pay $8.5M to settle whistleblower lawsuit over simultaneous surgeries

    The lawsuit alleges that UPMC’s longtime head of cardiothoracic surgery, James Luketich, regularly performed as many as three complex surgeries at the same time.

    By Feb. 28, 2023
  • A picture of the outside of Ascension St. Joseph hospital
    Image attribution tooltip

    Screenshot: Google Maps

    Image attribution tooltip

    Illinois nurses file class action lawsuit against Ascension over wage issues

    The lawsuit, filed on behalf of four current and former Illinois nurses, alleges that Ascension failed to properly pay employees and that the health system engaged in “improper” cost-cutting practices.

    By Feb. 27, 2023
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip
    Surprise Billing

    CMS says surprise billing arbitration can resume for some disputes — others remain on pause

    Regulators are continuing to work on new guidance in light of a court decision that ruled against the government and threw a wrench in the third-party process to resolve payment disputes between payers and providers.

    By Feb. 27, 2023
  • Exterior of FDA headquarters
    Image attribution tooltip
    Courtesy of U.S. Food and Drug Administration
    Image attribution tooltip

    FDA authorizes first at-home flu-COVID-19 combination test days after its developer files for bankruptcy

    Lucira filed for bankruptcy protection last week, saying the “protracted” authorization process caused it to miss out on test sales in the latest flu season.

    By Nick Paul Taylor • Feb. 27, 2023
  • Healthcare One year into COVID-19 crisis
    Image attribution tooltip
    Adeline Kon/Healthcare Dive
    Image attribution tooltip
    Opinion

    Partisan gridlock shouldn’t threaten true value in healthcare

    Oak Street CEO Mike Pykosz makes the case for value-based healthcare policy despite potential partisan gridlock in the 118th Congress.

    By Mike Pykosz • Feb. 24, 2023
  • Doctors operate on a patient.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Hospital lobby opposes noncompete ban, says ‘now is not the time to upend’ labor markets

    The American Hospital Association is pushing the FTC to abandon its proposal to eliminate restrictive covenants. At the very least, the lobby wants physicians and senior executives exempt.

    By Feb. 24, 2023
  • A picture of an Amazon Go store outside of Amazon HQ
    Image attribution tooltip
    David Ryder / Stringer via Getty Images
    Image attribution tooltip

    Amazon closes $3.9B buy of One Medical

    The acquisition, which closed without a challenge from regulators, gives Amazon a footprint in primary care and reinvigorates the company’s long-held plans to sell healthcare services to employers.

    By Feb. 22, 2023
  • A medical professional measures a patient's blood pressure using a sphygmomanometer.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    HIPAA complaints, breaches increased from 2017 to 2021 as HHS urges more funding

    The HHS Office for Civil Rights is facing a “severe strain” on its staff and budget amid rising breaches and complaints, according to the agency’s annual report to Congress.

    By Feb. 21, 2023
  • Medicaid redeterminations

    Medicaid enrollees largely unaware of upcoming redeterminations, survey finds

    About 64% of adults in a Medicaid-enrolled family said they didn’t know they could lose coverage once eligibility checks resume on April 1, a survey from the Robert Wood Johnson Foundation found.

    By Hailey Mensik • Feb. 21, 2023
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip
    Deep Dive // Medicaid redeterminations

    Could Medicaid redeterminations cause short-term health plan signups to spike?

    Short-term plan operators will likely ramp up their marketing in April to nab new consumers from the Medicaid churn, but health policy experts largely aren't concerned.

    By Feb. 21, 2023
  • The Federal Trade Commission headquarters is pictured in Washington, D.C. The agency's proposed noncompete ban may face legal challenges on several grounds.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    SUNY Upstate, Crouse Health System call off merger

    The Federal Trade Commission, which opposed the tie-up, cheered the news on Thursday. Previously, the agency had warned state lawmakers about the dangers of shielding hospital mergers from antitrust enforcement. 

    By Feb. 17, 2023
  • Image attribution tooltip
    Stefani Reynolds / Stringer via Getty Images
    Image attribution tooltip

    Lawmakers stress urgency of healthcare worker shortage

    Addressing the education pipeline is one issue legislators can focus on to improve nurse and physician shortages, medical school and health system leaders said during a Senate committee hearing.

    By Hailey Mensik • Feb. 16, 2023
  • An illustration of a stethoscope in the shape of a dollar sign.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Boston Scientific, MDMA call for more transparency, oversight of Medicare Advantage plans

    Privately offered Medicare Advantage plans “do not often provide a clear reason for the denial of coverage, and rarely offer any visibility into the evidence and methodology,” trade group MDMA and Boston Scientific said.

    By Nick Paul Taylor • Feb. 15, 2023
  • A picture of Xavier Becerra giving a speech at a podium
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    CMS plans trio of experiments aimed at lowering drug costs

    The pilot programs could allow adjusted payments for drugs cleared under accelerated approval and help states manage the costs of gene therapies.

    By Christopher Newman • Feb. 15, 2023
  • Doctors or nurses walking in hospital hallway, blurred motion
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Senator blasts Ascension, alleging it runs like private equity fund rather than nonprofit health system

    Sen. Tammy Baldwin, D-Wis., said the system “appears to be evaluating each staffing decision, service line, and hospital location as solely a business decision while seeking to bolster cash to put towards its investment funds.”

    By Hailey Mensik • Feb. 15, 2023
  • Surgical procedures cost significantly more at hospitals in networks versus independent facilities, study finds

    The median price for a shoulder arthroscopy was $4,432 at hospitals within a network, compared to $2,643 at independent hospitals, new research in JAMA Network Open found.

    By Hailey Mensik • Feb. 14, 2023
  • ONC head Micky Tripathi stands behind a podium.
    Image attribution tooltip
    Courtesy of HHS
    Image attribution tooltip

    ONC debuts first cohort of qualified networks in TEFCA, including Epic, eHealth Exchange

    Epic, CommonWell Health Alliance, eHealth Exchange, Health Gorilla, Kno2 and Konza — which collectively cover a significant swath of American health records — have committed to go live within TEFCA in 12 months.

    By Feb. 14, 2023
  • Federal Trade Commission
    Image attribution tooltip
    Carol Highsmith. (2005). "The Apex Building" [Photo]. Retrieved from Wikimedia Commons.
    Image attribution tooltip
    Deep Dive

    FTC’s enforcement action against GoodRx unveiled a new regulatory threat. Should digital health apps be concerned?

    The order suggests the regulator is willing to use every tool in its tookit to tamp down on sensitive data sharing as medical care turns increasingly online.

    By Feb. 13, 2023
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip
    Surprise Billing

    HHS pauses surprise billing arbitration after Texas court decision

    The process by which health insurers and medical providers hash out payments for surprise bills is still in flux due to a series of lawsuits threatening the dispute resolution process.

    By Feb. 13, 2023
  • The front of the department of health and human services building with a sign in front of the exterior building
    Image attribution tooltip
    Mark Wilson via Getty Images
    Image attribution tooltip

    Medicare to collect drug price rebates starting in 2025

    The CMS has laid out how it plans to implement a key provision of the Inflation Reduction Act requiring drugmakers to pay rebates on price hikes in Medicare that are greater than inflation.

    By Christopher Newman • Feb. 10, 2023
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images
    Image attribution tooltip

    HHS readies for PHE wind down, end of pandemic flexibilities

    A variety of pandemic-era policies will expire May 11, including those allowing providers to prescribe controlled substances via telehealth without an in-person visit and rules requiring payers to cover COVID-19 testing.

    By Hailey Mensik • Feb. 10, 2023
  • U.S. President Joe Biden delivers his State of the Union address during a joint meeting of Congress in the House Chamber of the U.S. Capitol on February 07, 2023 in Washington, DC.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biden zeroes in on drug costs during State of the Union address

    The president called for extending Medicare's $35 insulin price cap to all Americans and blasted “big pharma” for record profits while at the same time “unfairly charging people hundreds of dollars.”

    By Feb. 8, 2023
  • An illustration of a stethoscope in the shape of a dollar sign.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    MA enrollment grew 337% from 2006 through 2022, study finds

    Traditional Medicare lost 1 million enrollees over the same period, according to new research published in Health Affairs.

    By Hailey Mensik • Feb. 7, 2023